These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12837642)

  • 1. Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model.
    Bania TC; Ashar T; Press G; Carey PM
    Acad Emerg Med; 2003 Jul; 10(7):697-704. PubMed ID: 12837642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.
    Miotto K; Darakjian J; Basch J; Murray S; Zogg J; Rawson R
    Am J Addict; 2001; 10(3):232-41. PubMed ID: 11579621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
    Liao PC; Chang HM; Chen LY
    J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis in the context of sodium oxybate therapy.
    Langford J; Gross WL
    J Clin Sleep Med; 2011 Dec; 7(6):665-6. PubMed ID: 22171207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma hydroxybutyric acid (GHB) intoxication.
    Mason PE; Kerns WP
    Acad Emerg Med; 2002 Jul; 9(7):730-9. PubMed ID: 12093716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
    van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
    Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome.
    Kamal RM; Dijkstra BA; Loonen AJ; De Jong CA
    J Addict Med; 2016; 10(4):229-35. PubMed ID: 27310146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physostigmine does not effect arousal but produces toxicity in an animal model of severe gamma-hydroxybutyrate intoxication.
    Bania TC; Chu J
    Acad Emerg Med; 2005 Mar; 12(3):185-9. PubMed ID: 15741579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges.
    Colombo G; Agabio R; Lobina C; Reali R; Fadda F; Gessa GL
    Physiol Behav; 1995 Jan; 57(1):105-11. PubMed ID: 7878101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-hydroxybutyrate withdrawal syndrome.
    Dyer JE; Roth B; Hyma BA
    Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
    McDonough M; Kennedy N; Glasper A; Bearn J
    Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.
    van Nieuwenhuijzen PS; Long LE; Hunt GE; Arnold JC; McGregor IS
    Psychopharmacology (Berl); 2010 Dec; 212(4):663-74. PubMed ID: 20730418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
    Busardò FP; Jones AW
    Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons.
    Goodwin AK; Griffiths RR; Brown PR; Froestl W; Jakobs C; Gibson KM; Weerts EM
    Psychopharmacology (Berl); 2006 Nov; 189(1):71-82. PubMed ID: 17047936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons.
    Goodwin AK; Gibson KM; Weerts EM
    Drug Alcohol Depend; 2013 Oct; 132(3):427-33. PubMed ID: 23538206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
    J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
    Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
    Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons.
    Weerts EM; Goodwin AK; Griffiths RR; Brown PR; Froestl W; Jakobs C; Gibson KM
    Psychopharmacology (Berl); 2005 May; 179(3):678-87. PubMed ID: 15645222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
    Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
    Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.